Su Ho Park

Title: Su Ho Park - Innovator in Self-Immolative Linkers

Introduction

Su Ho Park is a notable inventor based in Daejeon, South Korea. She has made significant contributions to the field of biochemistry, particularly in the development of innovative compounds that enhance the delivery of active agents within target cells. Her work is characterized by a focus on self-immolative linkers that can be utilized in various applications, including drug delivery and targeted therapies.

Latest Patents

Su Ho Park holds a patent for a "Compound bearing beta-galactoside-introduced self-immolative linker." This invention relates to a compound that features a self-immolative linker with a β-galactoside moiety. The self-immolative linker is designed to form glycosidic bonds with proteins or ligands that have a specific affinity for desired targets. This innovative approach allows for the selective release of active agents, such as drugs or detection probes, within target cells, thereby enhancing therapeutic efficacy.

Career Highlights

Su Ho Park is currently associated with Intocell, Inc., where she continues to advance her research and development efforts. Her work has garnered attention for its potential applications in medical and pharmaceutical fields. With a focus on innovative solutions, she has established herself as a key figure in her area of expertise.

Collaborations

Su Ho Park collaborates with esteemed colleagues, including Tae Kyo Park and Sung Ho Woo. These partnerships enhance her research capabilities and contribute to the advancement of their shared goals in the field of biochemistry.

Conclusion

Su Ho Park is a pioneering inventor whose work on self-immolative linkers represents a significant advancement in targeted drug delivery systems. Her contributions continue to influence the field and hold promise for future innovations.